A new study reinforces the importance of lowering cholesterol in people at risk for but who haven't had a heart attack or stroke. The study looked at a statin alternative, called bempedoic acid, and ...

Those who took bempedoic acid once a day had on average a 30.2 mg/dL or 21.3% reduction in low-density lipoprotein (LDL) cholesterol levels over about a three-year period. Elevated LDL levels can lead ...

CLEVELAND, Ohio (Ivanhoe Newswire) – According to the CDC, about two in every five Americans struggle with high cholesterol. If left untreated, it could lead to heart disease or stroke. Statins are ...

(WNDU) - According to the CDC, about two in every five Americans struggle with high cholesterol. If left untreated, it could lead to heart disease or stroke. Statins are usually the gold standard for ...

When it comes to lowering high levels of low-density lipoprotein cholesterol (LDL-C), sticking to the status quo is not meeting the needs of millions of Americans. That’s a major concern, because ...

What was unknown until now, is whether bempedoic acid also reduced the risk of cardiovascular events. Now, the results of a randomized, controlled trial published in The New England Journal of ...

An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds. When taken as a daily pill, bempedoic acid lowered ...

An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds. When taken as a daily pill, bempedoic acid lowered ...

Dear Dr. Roach: In a recent column, you wrote about reducing cholesterol with the help of statins along with a PCSK9i, such as Repatha or Praluent. My question is: Are these PCSK9is at all beneficial ...

When the FDA approved bempedoic acid, marketed under the brand name Nexletol, back in 2020, it was clear that the drug helped lower LDL — "bad" cholesterol. The drug was intended for people who can't ...